HMD launches first made in India dispovan insulin pen needle

The device has been precision engineered by Hindustan Syringes & Medical Devices as an affordable sterile single-use pen needle, which can be universally fitted on all international brands of insulin pens


New Delhi: Diabetes is one of the most prevalent diseases in the world. It has been projected that worldwide approximately 300 million people would be afflicted with it by 2025. In India, about 50.9 million people suffer from Diabetes, and this figure is likely to go upto 80 million by 2025, making it the ‘Diabetes Capital’ of the world. Delhi alone has an estimated 29.8 lakh people suffering from this disease (Indo-US collaborative study).

Now in a development that is expected to boost the affordable medtech innovation, the Hindustan Syringes & Medical Devices (HMD) has launched most revolutionary and pioneering, India’s First “Made in India” Dispovan Insulin Pen Needle” to provide better comfort for people with diabetes at the 4th Medical Expo Indore 2018.

As per HMD, the Dispovan Insulin pen needle is a precision engineered, yet affordable sterile single use pen needle, which can be universally fitted on all international brands of Insulin Pens. With features like ergonomic shape for improved skin contact and grip, extra thin wall, multi-bevel, tapered point, Dispovan Insulin pen needle is designed and manufactured by HMD with intent to offer a much less painful injection experience for diabetic patients.

According to Mr Rajiv Nath, Joint Managing Director of Hindustan Syringes & Medical Devices (HMD), “We are particularly excited about the prospects of our latest offering ” Dispovan Insulin Pen Needle” manufactured in our state of the art manufacturing facilities, which will end India’s import dependency and the monopoly of BD. Patients will now be able to access an affordable quality product, which they need not reuse because it is expensive. We have received excellent feedback and clinical acceptance from the end users of a comfortable injection and glad that our investments in high end technology are giving us a competitive edge.”

“With the launch of ‘Dispovan Insulin Pen Needle’ we will contribute towards our ongoing commitment of making healthcare affordable for common people in India” said Mr Pardeep Sareen, Chief General Manager-Marketing of HMD .

“Why reuse a pen needle”, he quipped “when Dispovan makes it affordable for single use? Reuse of an Insulin pen needle could increase the bacterial growth on the needle which could lead to risk of injection, experiencing pain when injecting, risk of lipohypertrophy (lumpy skin) occurring, and risk of the very fine tip of the needle breaking off. All these risks will grow with each re-use”, he advised.

Dispovan Insulin Pen Needle is manufactured at HMD’s Faridabad-Ballabgarh plant. The new plant is spread on an area of 5.5 acres and will have the capacity to initially produce over 100 million units per annum of ‘Dispovan Insulin Pen Needle’ to meet the rising export and domestic demand for its new technology. Every Needle point is checked online by a Digital Vision Camera System for a defective, blunt needle point and such needles, which can be potentially painful are rejected automatically on line, he explained. The proprietary dry silicon coating used by us makes the needle surface slippery to ensure comfortable injection.

Dispovan Insulin Pen Needle has needle gauge option of 31G & 32G with needle length of 5mm & 4mm respectively and comes in purple and green colour shade to enable visual recognition of needle size.

The pricing of the Dispovan pen needle has been kept at Rs 12 which is economical to patient by at least 15 %, as compared to imported pen needles. Unlike prices of imports that are volatile and linked to ever changing exchange rates and steady devaluation of Indian rupee that makes imports expensive, the made in India product has relatively stable pricing.